Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Unresectable or Metastatic Renal Cell Carcinoma
NCT00586105Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2005
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of sorafenib in renal cell carcinoma (RCC), sponsored by Bayer. Started Dec 2005; status: completed.
02
Drugs
sorafenib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00586105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00586105.